Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 5
1970 3
1971 2
1972 7
1973 6
1974 1
1975 9
1976 6
1977 1
1978 5
1979 2
1980 2
1982 1
1983 2
1984 2
1985 2
1986 3
1987 3
1988 6
1989 1
1990 4
1991 4
1992 2
1993 3
1994 5
1995 1
1996 1
1997 1
1998 2
1999 2
2001 3
2003 1
2004 4
2006 1
2008 3
2009 2
2010 2
2013 2
2014 2
2015 1
2016 1
2017 1
2018 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
Rapoport AP, Stadtmauer EA, Binder-Scholl GK, Goloubeva O, Vogl DT, Lacey SF, Badros AZ, Garfall A, Weiss B, Finklestein J, Kulikovskaya I, Sinha SK, Kronsberg S, Gupta M, Bond S, Melchiori L, Brewer JE, Bennett AD, Gerry AB, Pumphrey NJ, Williams D, Tayton-Martin HK, Ribeiro L, Holdich T, Yanovich S, Hardy N, Yared J, Kerr N, Philip S, Westphal S, Siegel DL, Levine BL, Jakobsen BK, Kalos M, June CH. Rapoport AP, et al. Among authors: finklestein j. Nat Med. 2015 Aug;21(8):914-921. doi: 10.1038/nm.3910. Epub 2015 Jul 20. Nat Med. 2015. PMID: 26193344 Free PMC article.
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.
Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S, Finklestein JZ, Gorr TA, Mehta P, Schmid I, Kropshofer G, Corbacioglu S, Lang PJ, Klein C, Schlegel PG, Heinzmann A, Schneider M, Starý J, van den Heuvel-Eibrink MM, Hasle H, Locatelli F, Sakai D, Archambeault S, Chen L, Russell RC, Sybingco SS, Ohh M, Braun BS, Flotho C, Loh ML. Niemeyer CM, et al. Among authors: finklestein jz. Nat Genet. 2010 Sep;42(9):794-800. doi: 10.1038/ng.641. Epub 2010 Aug 8. Nat Genet. 2010. PMID: 20694012 Free PMC article.
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.
Teachey DT, Lacey SF, Shaw PA, Melenhorst JJ, Maude SL, Frey N, Pequignot E, Gonzalez VE, Chen F, Finklestein J, Barrett DM, Weiss SL, Fitzgerald JC, Berg RA, Aplenc R, Callahan C, Rheingold SR, Zheng Z, Rose-John S, White JC, Nazimuddin F, Wertheim G, Levine BL, June CH, Porter DL, Grupp SA. Teachey DT, et al. Among authors: finklestein j. Cancer Discov. 2016 Jun;6(6):664-79. doi: 10.1158/2159-8290.CD-16-0040. Epub 2016 Apr 13. Cancer Discov. 2016. PMID: 27076371 Free PMC article.
Human subtelomeric DNA.
Riethman H, Ambrosini A, Castaneda C, Finklestein JM, Hu XL, Paul S, Wei J. Riethman H, et al. Among authors: finklestein jm. Cold Spring Harb Symp Quant Biol. 2003;68:39-47. doi: 10.1101/sqb.2003.68.39. Cold Spring Harb Symp Quant Biol. 2003. PMID: 15338601 Review. No abstract available.
Neuroblastoma.
Groncy P, Finklestein JZ. Groncy P, et al. Among authors: finklestein jz. Pediatr Ann. 1978 Aug;7(8):548-59. Pediatr Ann. 1978. PMID: 693075 No abstract available.
Recent advances in neuroblastoma.
Finklestein JZ, Gilchrist GS. Finklestein JZ, et al. Calif Med. 1972 Mar;116(3):27-36. Calif Med. 1972. PMID: 4622580 Free PMC article.
Congenital aggressive lipomatosis.
Lachman RS, Finklestein J, Mehringer CM, Maenza R. Lachman RS, et al. Among authors: finklestein j. Skeletal Radiol. 1983;9(4):248-54. doi: 10.1007/BF00354126. Skeletal Radiol. 1983. PMID: 6867775
Remaining problems in the treatment of patients with Wilms' tumor.
Green DM, Finklestein JZ, Breslow NE, Beckwith JB. Green DM, et al. Among authors: finklestein jz. Pediatr Clin North Am. 1991 Apr;38(2):475-88. doi: 10.1016/s0031-3955(16)38088-9. Pediatr Clin North Am. 1991. PMID: 1848690 Review.
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy.
Wilson J, Kimmel B, Arora K, Chada N, Bharti V, Kwiatkowski A, Finklestein J, Hanna A, Arner E, Sheehy T, Pastora L, Yang J, Pagendarm H, Stone P, Taylor B, Hubert L, Gibson-Corley K, May J, McLean J, Rathmell J, Richmond A, Rathmell W, Balko J, Fingleton B, Hargrove-Wiley E. Wilson J, et al. Among authors: finklestein j. Res Sq [Preprint]. 2024 May 8:rs.3.rs-3243545. doi: 10.21203/rs.3.rs-3243545/v1. Res Sq. 2024. PMID: 38766114 Free PMC article. Preprint.
118 results